Center for Immunology Science

Center for Immunology ScienceCenter for Immunology ScienceCenter for Immunology Science
  • Home
  • FIBROMYALGIA TRIAL
  • IMBXX
  • IBS research
  • Long Covid research
  • Contact
  • More
    • Home
    • FIBROMYALGIA TRIAL
    • IMBXX
    • IBS research
    • Long Covid research
    • Contact

Center for Immunology Science

Center for Immunology ScienceCenter for Immunology ScienceCenter for Immunology Science
  • Home
  • FIBROMYALGIA TRIAL
  • IMBXX
  • IBS research
  • Long Covid research
  • Contact

IBS Research

Participate Now

We are pleased to announce that a clinical trial has been developed to address IBS. A University College of Pharmacy developed this breakthrough compound with potential curative effects. The trial will start on August 12th at the Center for Immunology Science in West Los Angeles. We are looking for volunteers to come to our laboratory for a 1-hour seminar, receive a 30-day supply of the compound, and once a week, fill out an online journal that will take about 5 minutes each week. The trial will only last 30 days. Please note the compound is 100% non-toxic, vegan and safe. This is phase 2 of the trial. 


Center for Immunology Science

Los Angeles, CA

research@cimsx.com

Copyright © 2024 Center for Immunology Science - All Rights Reserved.


Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept

FIBROMYALGIA TRIAL HAS STARTED!

SEE IF YOU QUALIFY!

Learn more